Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The stable introduction of a functional beta-globin gene in haematopoietic stem cells could be a powerful approach to treat beta-thalassaemia and sickle-cell disease. Genetic approaches aiming to increase normal beta-globin expression in the progeny of autologous haematopoietic stem cells might circumvent the limitations and risks of allogeneic cell transplants. However, low-level expression, position effects and transcriptional silencing hampered the effectiveness of viral transduction of the human beta-globin gene when it was linked to minimal regulatory sequences. Here we show that the use of recombinant lentiviruses enables efficient transfer and faithful integration of the human beta-globin gene together with large segments of its locus control region. In long-term recipients of unselected transduced bone marrow cells, tetramers of two murine alpha-globin and two human betaA-globin molecules account for up to 13% of total haemoglobin in mature red cells of normal mice. In beta-thalassaemic heterozygous mice higher percentages are obtained (17% to 24%), which are sufficient to ameliorate anaemia and red cell morphology. Such levels should be of therapeutic benefit in patients with severe defects in haemoglobin production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After establishing that β-globin lentiviral vectors had successfully corrected models of β-thalassemia and sickle cell disease in mice, 17,18 we initiated a human clinical study of ex vivo gene therapy for the β-hemoglobinopathies”
From Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia (2018) · cites this paper as [17]
Citations
Cites
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Position-independent, high-level expression of the human β-globin gene in transgenic mice
Grosveld, F., van Assendelft, G. B., Greaves, D. R., & Kollias, G. (1987) · Cell · doi:10.1016/0092-8674(87)90584-8 · Cited by 1,909 · cited 1×
“, referred to as the locus control region (LCR), are linked to the globin gen”
BackgroundMalim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., & Cullen, B. R. (1989) · Nature · doi:10.1038/338254a0 · Cited by 1,280 · cited 1×
“Here we report how these problems may be overcome by using vectors derived from human immunodeficiency virus 1, a retrovirus that has the ability to regulate packaging of unspliced viral genome”
Hematology of Infancy and Childhood.
(1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-587_2 · Cited by 892
The Molecular Basis of Blood Diseases.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-950_3 · Cited by 632
Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., & Torbett, B. E. (1999) · Science · doi:10.1126/science.283.5402.682 · Cited by 624
The "beta-like-globin" gene domain in human erythroid cells.
Tuan, D., Solomon, W., Li, Q., & London, I. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6384 · Cited by 601 · cited 1×
“The same outcome prevails in transgenic mice unless genomic elements encompassing DNase I hypersensitive sites (HS) located 60 kilobases (kb) upstream of the human β-globin gen”
BackgroundLooping versus linking: toward a model for long-distance gene activation
Bulger, M., & Groudine, M. (1999) · Genes & Development · doi:10.1101/gad.13.19.2465 · Cited by 484
Raj, S. R., Chen, S. R. W., Sheldon, R. S., Shah, A. N., Kantharia, B. K., Salzer, U., Grimbacher, B., Leung, A. K. C., Kamat, D., Kolovou, G. D., et al. (2009) · Encyclopedia of Molecular Mechanisms of Disease · doi:10.1007/978-3-540-29676-8_1731 · Cited by 475
Cited by
Items 501–600 of 622
Stem Cell Technology and Other Innovative Therapies
(2007) · Libreria Editrice Vaticana eBooks · doi:10.65398/gesm1245 · Cited by 1
Hematopoietic stem cells and their dynamics
Dingli, D., Traulsen, A., & Pacheco, J. M. (2009) · Max Planck Institute for Plasma Physics · Cited by 1
Correlation of Hemoglobin with Lung Function Tests
Jahangir, S., Asad, A., & Butt, I. F. (2015) · Journal of Islamic International Medical College · Cited by 1
Surbek, D., Wagner, A. M., & Schoeberlein, A. (2009) · Wiley eBooks · doi:10.1002/9780470480151.ch4 · Cited by 1
Adapting in vitro embryonic stem cell differentiation to the study of locus control regions
Lahiji, A., Kučerová-Levisohn, M., Holmes, R., Zúñiga‐Pflücker, J. C., & Ortiz, B. D. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.03.012 · Cited by 1
“This approach has already been taken in the design of vectors containing β-globin LCR components (May et al., 2000).”
Recent Advances and Future Perspectives in Lentiviral Gene Therapy for Hemophilia A and B
Mátrai, J., Chuah, M., & VandenDriessche, T. (2012) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s1-004 · Cited by 1
Development and Recent Progresses of Gene Therapy for β-Thalassemia
Acuto, S., Baiamonte, E., Stefano, R. D., Spina, B., Barone, R. M. E., & Maggio, A. (2014) · Thalassemia Reports · doi:10.4081/thal.2014.2925 · Cited by 1
In silico mutation analysis of human beta globin gene in sickle cell disease patients
Mubeen, H., Naqvi, R. Z., Masood, A., Shoaib, M., & Raza, S. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20161247 · Cited by 1
LiPS-A3S, a human genomic site for robust expression of inserted transgenes
Kotini, A. G., Sadelain, M., & Papapetrou, E. P. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.99 · Cited by 1
Self-citationGene Therapy: The Path Toward Becoming a Realistic Cure for Sickle Cell Disease
Leonard, A. K., & Abraham, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62328-3_15 · Cited by 1
Hematopoietic Progenitor Cells
Lin, K., Sirin, O., & Goodell, M. A. (2008) · CRC Press eBooks · doi:10.1201/9780849387999.pt4 · Cited by 1
Eighth Cooley's Anemia Symposium: Summation and Perspective
Nienhuis, A. W. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.048 · Cited by 1
A functional screen for regulatory elements that improve retroviral vector gene expression
Groth, A. C., & Emery, D. W. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.08.005 · Cited by 1
Kohn, D. B., Carter, B. J., Grandi, P., & Glorioso, J. C. (2009) · Wiley eBooks · doi:10.1128/9781555815981.ch16 · Cited by 1
Farrow, N. (2016) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.4225/55/583e30e1b3865 · Cited by 1
Gene Editing of Bruton's Tyrosine Kinase for Treatment of X-Linked Agammaglobulinemia
Gray, D. (2020) · eScholarship (California Digital Library) · Cited by 1
Pharmacologically controlled neurotrophic factor gene therapy for Parkinson's disease
Cheng, S. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7576 · Cited by 1
Engineering high-titer lentiviral vectors for robust expression of RNA-based gene circuitsPreprint
Love, K. S., Lende-Dorn, B. A., & Galloway, K. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.12.724401 · Cited by 1
Recent Advances in Approaches to the Study of Gene Locus Control Regions
Ortiz, B. D. (2014) · Springer proceedings in mathematics & statistics · doi:10.1007/978-3-319-07755-0_9
Adeno Associated Virus Mediated β-Thalassemia Gene Therapy
Tan, M., Sun, X., Zhenqing, Song, L., Jing, Xiaolin, & , X. (2011) · InTech eBooks · doi:10.5772/20482
Gene Therapy of Genetic Diseases of Blood Cells
Kuftinec, G. N., Wherley, J., & Kohn, D. B. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200019
Expression Targeting in Gene Therapy
Vassaux, G., & Leverton, K. E. (2006) · Wiley eBooks · doi:10.1038/npg.els.0005747
Animal Models of Hemoglobinopathies and Thalassemia
Fabry, M. E. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.017
Can genetic engineering of red blood cells and transfusion become close friends?
Bagnis, C. (2011) · ISBT Science Series · doi:10.1111/j.1751-2824.2011.01429.x
Gene Therapy for Chronic Myelogenous Leukemia
Verfaillie, C. M., & Zhao, R. C. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50021-5
Maina, C. N. (2009) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1689
Γονιδιακή μεταφορά σε αιμοποιητικά κύτταρα με επισωματικά αυτο-αναπαραγόμενα οχήματα
Σταύρου, Ε. (2005) · Νημερτής
Haemoglobin Disorders: Gene Therapy
Persons, D. A., & Nienhuis, A. W. (2009) · Wiley eBooks · doi:10.1002/9780470015902.a0006041.pub2
Globin gene regulation for treating β-thalassemias: progress, obstacles and future
Saliba, A. N., Alameddine, R. S., Harb, A., & Taher, A. T. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1074071
Prospects for Gene Therapy of Sickle Cell Disease and Thalassemia
Persons, D. A., Sorrentino, B. P., & Nienhuis, A. W. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.044
A “Vector Drain” in US Gene Therapy Development?
Sadelain, M., & Williams, D. A. (2008) · Molecular Therapy · doi:10.1038/mt.2008.71
“6 The first tissue-restricted lentiviral vectors, exemplified by the TNS9 vector developed in New York”
BackgroundSelf-citationOne step closer to gene therapy for hemoglobinopathies
Sorrentino, B. P. (2004) · Blood · doi:10.1182/blood-2004-09-3516
Lentiviral vector for hemophilia gene therapy
Herzog, R. W. (2004) · Blood · doi:10.1182/blood-2004-03-0820
Ex vivo expansion of hematopoietic stem cells for use in nonmyeloablative transplantation
Bakovic, S., Ohta, H., Imren, S., Cavilla, B., Eaves, C. J., & Humphries, R. K. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.048
Lentiviruses for stable gene therapy
Dove, A. (2000) · Nature Biotechnology · doi:10.1038/78375
Aspectos actuales y previsiones de futuro de la terapia génica
Martín, M. A. S., & García, I. S. (2002) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(02)70825-1
Approaches to Management of Beta-Thalassemia Intermedia
Maakaron, J. E., & Taher, A. T. (2013) · Thalassemia Reports · doi:10.4081/thal.2013.s1.e12
BVL-1–like VL30 promoter sustains long-term expression in erythroid progenitor cells
Staplin, W. R., & Knezetic, J. A. (2003) · Blood · doi:10.1182/blood-2002-07-2105
Modernizing Disease Management: A Question of Priorities
Weisberg, S. P. (2000) · JAMA · doi:10.1001/jama.284.21.2784-jms1206-2-1
Characterization of the Sleeping Beauty transposon system for gene therapy applications
Score, P. R. (2008) · University of Minnesota Digital Conservancy (University of Minnesota)
Gene therapy: A novel way to treat respiratory failure?
Kamoun, P. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.03.012
Immunodeficiency Syndromes: Gene Therapy
Fischer, A. (2006) · Wiley eBooks · doi:10.1038/npg.els.0005752
Therapeutic induction of tolerance to reverse allergen-induced airway inflammation
Kouba, J. A. (2015) · The University of Queensland · doi:10.14264/uql.2015.919
“However, HIV-1 based vectors have advanced in safety and versatility and have been the most used in preclinical gene therapy studies (May et al. 2000, Woods et al. 2000).”
Beuzard, Y., Bushman, F. D., Leboulch, P., Payen, E., Nègre, O., Fusil, F., Colomb, C., Roth, S. L., & Gillet-Legrand, B. (2012)
Yazdi, F. (2015) · MacSphere (McMaster University) · doi:10.71548/7837
Neuroprotection of cone photoreceptors in retinitis pigmentosa
Lipinski, D. M., & Lipinski, D. M. (2013) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-nrgn4gyz5
NEW APPROACHES TO THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIA
Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.039
Site-directed integration using the Cre/lox system in hematopoietic and embryonic stem cells
Faulkes, S. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0090532
Lee, J. Q. Y. (2011) · ScholarSpace (University of Hawaii at Manoa)
Role of Sox6 and Coup-TFII transcription factors in the regulation of hemoglobin switching
Elangovan, S. (2014) · BOA (University of Milano-Bicocca)
Gene Therapy for Sickle Cell Disease: A Safety/Efficacy Trial
Hexner, E. O. (2001)
Cavilla, B. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0090800
Hematopoietic Progenitor Cells
McKinney-Freeman, S. L., Bradfute, S. B., & Goodell, M. A. (2000) · CRC Press eBooks · doi:10.1201/9781420002126-50
Desogus, M. (2016) · VEprints - Universita degli Studi di Cagliari
Davis, B. R., & Prokopishyn, N. L. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374729-7.00065-2
McNichol, R. M. (2007) · CORE Scholar (Wright State University)
Correction of Genetic Blood Defects by Gene Transfer
Cavazzana, M., Hacein‐Bey‐Abina, S., Thrasher, A. J., Leboulch, P., & Fischer, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_88
The State of the Field and the Future
Chandrakasan, S., & Malik, P. (2014)
Allogeneic Hematopoietic Cell Transplants for Sickle Cell Disease
Weitzel, R. P., Fitzhugh, C. D., & Tisdale, J. F. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.056
Hematopoietic Cell Transplants for Non-Neoplastic Diseases
Abutalib, S. A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.053
MDS1/EVI1 and PRDM16 deregulation in hematopoiesis after experimental and clinical gene transfer
Wang, W. (2012) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00013202
Mechanism of Human Hematopoietic Stem Cell Loss during Ex Vivo Manipulation and Gene Transfer
Shrestha, A., Higashimoto, T., Felker, S., Loberg, A., Jayavaradhan, R., Hinge, A. S., Pillis, D. M., Kaufman, K. M., Filippi, M., & Malik, P. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.06.147
Gene Therapy for Nonmalignant Hematology
Wang, X., & Rivière, I. (2018) · Advances and controversies in hematopoietic transplantation and cell therapy · doi:10.1007/978-3-319-54368-0_14
Role of Retroviral vector-based Interventions in Combating Virus Infections
Khanna, M., Manocha, N., Himanshi, Joshi, G., Saxena, L., & Saini, S. (2019) · Future Virology · doi:10.2217/fvl-2018-0151
Davis, B. R., & Prokopishyn, N. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00077-9
A Review of Gene Editing/Therapy and CRISPR Technology
Ong, K. S., Lim, Z. S. T., & Setiawan, B. (2019) · Cermin Dunia Kedokteran · doi:10.55175/cdk.v46i6.441
Stiefelhagen, M., Sellner, L., Kleinschmidt, J. A., Jauch, A. S., Laufs, S., Wenz, F. K., Zeller, W. J., Früehauf, S., & Veldwijk, M. R. (2015)
Therapeutic Application of Hematopoietic Stem Cells
Xie, X., Pei, H., & Pei, X. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64046-8.00441-9
Klefenz, H. (2002) · Wiley eBooks · doi:10.1002/3527600124.refs
Hemoglobin Disorders: Gene Therapy
Persons, D. A., & Nienhuis, A. W. (2006) · Wiley eBooks · doi:10.1038/npg.els.0006041
Solter, D., Beyleveld, D., Friele, M. B., Hołówka, J., Lilie, H., Lovell-Badge, R. H., Mandla, C., Martin, U., & Avellaneda, R. P. (2003) · Springer eBooks · doi:10.1007/978-3-662-05117-7_12
Li, Z., Li, W., Li, Y., Zhao, W., Wu, J., Li, B., Maina, N., Bischof, D., Qing, K., Weigel-Kelley, K. A., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-193
Li, Z., Li, W., Li, Y., Zhao, W., Wu, J., Li, B., Maina, N., Bischof, D., Qing, K., Weigel-Kelley, K. A., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-179
Cao, A., & Galanello, R. (2004) · Informa Healthcare eBooks · doi:10.3109/9780203997352.024
Therapeutic Options for Patients with Severe ? -Thalassemia: The Need for Globin Gene Therapy
Sadelain, M., Boulad, F., Galanello, R., Giardina, P. J., Locatelli, F., Maggio, A., Rivella, S., Rivière, I., & Tisdale, J. F. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-272
Self-citationLes thérapies géniques des hémoglobinopathies : une nouvelle ère, mais à quel prix ?
Beuzard, Y. (2022) · Hématologie · doi:10.1684/hma.2022.1753
Reducing the transcriptional read‐through rate of a lentiviral vector for β‐thalassemia gene therapy
Wu, J., Chen, Y., Shen, W., Zhang, J., & Zeng, F. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3640
Thalassemia (Beta-Thalassemia)
-, T. P. A., -, G. P. P., & -, D. G. S. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i06.10390
Ramadier, S. (2020) · theses.fr (ABES) · doi:10.70675/b75724f6zb386z4f05zae5dzc8f17b350499
Manu on Lenti G2B Gene Therapy for β-ThalassemiaPreprint
Zhang, X., Gao, Z., Yang, Z.-X., Deng, D.-H., Zhang, F., Zhang, Z., Yu, B., Zhang, Y., Lv, X., Nakamura, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4249953/v1
Toward life without sickle cell disease
Davé, U. P., & Bungert, J. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.004
Lentiviral vector-mediated gene therapy for hematopoietic stem cells
Uchida, N. (2024) · Drug Delivery System · doi:10.2745/dds.39.267
Lundstrom, K. H. (2025) · Springer eBooks · doi:10.1007/978-3-031-77911-4_16
Gene Therapy for Nonneoplastic Hematologic and Histiocytic Disorders
Washington, K. N., Tisdale, J. F., & Hsieh, M. M. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_45
Sviluppo di vettori virali per la terapia genica della β−Talassemia
Cabriolu, A. (2012) · UNICA IRIS Institutional Research Information System (University of Cagliari)
The effect of cisplatin and chromatin structure at the human beta-globin locus control region
Davies, N. P. (2004) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/6508
CtBP represses adult β-like globin expression in haematopoiesis
Yik, J. (2017) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/19981
García-Bates, T. M., & Phipps, R. P. (2008) · UR Research (University of Rochester)
Using Nucleic Acids to Repair β-Globin Gene Mutations
Kierlin-Duncan, M. N. (2007) · DukeSpace (Duke University)
Biotecnologie applicate a studi pre-clinici di medicina rigenerativa e terapia genica.
Stefano, R. D. (2012) · Nova Science Publishers (Nova Science Publishers, Inc.)
Genetic Approaches To Treat Beta-Thalassemia
Dong, A. (2017) · eCommons (Cornell University)
Segura, E. (2025) · eScholarship (California Digital Library)
Metadata
- Authors
- May, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K. M. L., Luzzatto, L., & Sadelain, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California, San Francisco (US)
- Corresponding author
- Sadelain, Michel
- Venue
- Nature
- Published
- 2000-07
- Volume
- 406
- Issue
- 6791
- Pages
- 82-86
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1997170085
- Cited by
- 567
- References
- 34
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 10 · 2019: 16 · 2018: 26 · 2017: 18 · 2016: 16 · 2015: 15 · 2014: 13 · 2013: 22 · 2012: 24
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- James S. McDonnell Foundation
- National Heart, Lung, and Blood Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- beta-thalassemia, sickle cell disease, lentiviral transduction, human beta-globin gene, hematopoietic stem cells, locus control region, hemoglobin synthesis, anemia, erythrocyte morphology, position effect, transcriptional silencing
- MeSH terms
- Animals, Cell Line, Female, Genetic Vectors, Globins, Hemoglobins, Humans, Male, Recombinant Proteins, Transduction, Genetic, Genetic Therapy, HIV-1, Bone Marrow Transplantation, Lentivirus, beta-Thalassemia, Gene Transfer Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.